ENDRA LIFE SCIENCES INC. Cost of Revenue
ENDRA LIFE SCIENCES INC. (NDRA) reported Cost of Revenue of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2021-03-25
- ENDRA LIFE SCIENCES INC. cost of revenue for fiscal 2020 was $0.00.
- ENDRA LIFE SCIENCES INC. cost of revenue for fiscal 2019 was $0.00.
- ENDRA LIFE SCIENCES INC. cost of revenue for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- ENDRA LIFE SCIENCES INC. cost of revenue for fiscal 2017 was $172.78K.
| Period end | Cost of Revenue 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
| 2017-12-31 | $172.78K 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |